Wednesday, 02 September 2026 · World
USD/EUR 0.8625 USD/GBP 0.7394 USD/JPY 160.1 USD/CNY 6.737 All rates →
RSS
EUROS The World Financial Report
Nº 53 Wednesday, 02 September 2026 · World Edition
LATEST
Priority Jewels IPO allotment in focus today: GMP signals 15% listing pop | How to check share allotment status online?Asian markets today: South Korea’s Kospi, Japan's Nikkei 225 fall up to 3% amid fresh concerns around US-Iran warDeepa Jewellers IPO Day 2: GMP hints 25% listing gain. Check subscription, review, key dates. Apply or skip?Japanese green tea giant Ito En surges 8%, defying a broad market sell-offAustralia posts second-quarter growth of 2.1%, beating expectationsBuy or sell: Gift Nifty signals tepid start | Vaishali Parekh recommends three stocks to buy today —2 September 2026South Korea, Japan discuss cooperation on emergency energy supplyChina approves string of ‘telepathy’ devices amid push to leapfrog Elon MuskPriority Jewels IPO allotment in focus today: GMP signals 15% listing pop | How to check share allotment status online?Asian markets today: South Korea’s Kospi, Japan's Nikkei 225 fall up to 3% amid fresh concerns around US-Iran warDeepa Jewellers IPO Day 2: GMP hints 25% listing gain. Check subscription, review, key dates. Apply or skip?Japanese green tea giant Ito En surges 8%, defying a broad market sell-offAustralia posts second-quarter growth of 2.1%, beating expectationsBuy or sell: Gift Nifty signals tepid start | Vaishali Parekh recommends three stocks to buy today —2 September 2026South Korea, Japan discuss cooperation on emergency energy supplyChina approves string of ‘telepathy’ devices amid push to leapfrog Elon Musk
Front Page

Oklo Shares Down 46% Year-To-Date Amid Regulatory Delays

EUROS Newsroom · 18 Jul 2026 · 1 min read
Oklo Shares Down 46% Year-To-Date Amid Regulatory Delays

Oklo shares have fallen 46% this year and 75% from their peak as the advanced nuclear startup awaits regulatory approval to commercialize its first reactors.

Oklo shares have dropped 46% in 2026, currently trading 75% below their 52-week high. The steep selloff marks a sharp reversal for the advanced nuclear energy company, which was widely considered Wall Street's top AI energy pick just a year ago. The decline is driven by ongoing regulatory bottlenecks and the reality that the company has yet to generate commercial revenue.

The fundamental challenges pressuring the stock are not new. Oklo is unprofitable, has no commercial track record, and remains entirely dependent on clearing the Nuclear Regulatory Commission's approval process. While the long-term investment thesis hinges on the massive power demands of AI data centers, short-term traders have grown impatient with the slow pace of these regulatory milestones.

From a balance sheet perspective, the company is not constrained by capital. Oklo holds approximately $2.5 billion in total liquidity, giving it ample runway to weather the current regulatory timeline. Operationally, the firm recently notched a critical milestone by clearing the Department of Energy's final safety approval for its Groves Isotope Reactor in Texas.

Oklo's flagship technology, the Aurora powerhouse, presents a distinct engineering shift from legacy nuclear infrastructure. By utilizing a liquid sodium coolant, the reactor operates at higher temperatures and lower pressures than traditional water-cooled models. The compact design relies on inherent safety features rather than external cooling pumps. Crucially, it can consume both highly enriched and recycled nuclear fuels.

This fuel flexibility is central to Oklo's long-term supply chain strategy. The company is developing an internal fuel recycling program, which could eventually allow it to self-supply its reactors and sidestep constraints in the nation's limited nuclear fuel supply.

The underlying corporate demand for this technology remains evident. Oklo has secured strategic partnerships with Meta Platforms, Nvidia, and Centrus Energy, backed by early investment from Sam Altman. For institutional investors, the 46% year-to-date drop signals a market repricing: the stock is no longer trading on AI hype, but strictly on the company's ability to execute its regulatory roadmap.